Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

BACKGROUND: Non‐valvular atrial fibrillation (NVAF) patients are advised to switch from a vitamin K antagonist (VKA) to direct oral anticoagulant (DOAC) when time in therapeutic range (TTR) is low. OBJECTIVE: To examine if pre‐switch TTR determines persistence patterns in NVAF patients who are switc...

Descripción completa

Detalles Bibliográficos
Autores principales: Toorop, Myrthe M. A., Chen, Qingui, Kruip, Marieke J. H. A., van der Meer, Felix J. M., Nierman, Melchior C., Faber, Laura, Goede, Lies, Cannegieter, Suzanne C., Lijfering, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
HAEMOSTASIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299168/
https://www.ncbi.nlm.nih.gov/pubmed/34779140
http://dx.doi.org/10.1111/jth.15592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299168/
https://www.ncbi.nlm.nih.gov/pubmed/34779140
http://dx.doi.org/10.1111/jth.15592

Ejemplares similares